Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06508489
What this trial is testing

Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological Malignancies

Who this might be right for
Acute Myeloid Leukemia
Sanofi 7
Early research (Phase 1)Temporarily pausedNCT04828174
What this trial is testing

Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies

Who this might be right for
Peripheral T Cell LymphomaAngioimmunoblastic T-cell LymphomaAnaplastic Lymphoma+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 9
Early research (Phase 1)WithdrawnNCT01751243
What this trial is testing

Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies

Who this might be right for
Transplant-Related Hematologic Malignancy
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
Testing effectiveness (Phase 2)UnknownNCT04764513
What this trial is testing

Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndromes+1 more
Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00143559
What this trial is testing

Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies

Who this might be right for
LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+6 more
St. Jude Children's Research Hospital 17
Testing effectiveness (Phase 2)UnknownNCT00580450
What this trial is testing

Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies

Who this might be right for
Hematological Malignancies
University Of Perugia 9
Not applicableEnded earlyNCT02844491
What this trial is testing

Study of T Specific Immune Response Against Delta-CD20 Peptide in Hematological Malignancies B

Who this might be right for
Hematological Malignancies B
Centre Hospitalier Universitaire de Besancon 28
Testing effectiveness (Phase 2)Ended earlyNCT00861965
What this trial is testing

Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers

Who this might be right for
Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma
Mirror Biologics, Inc. 2
Not applicableEnrolling By InvitationNCT06985576
What this trial is testing

Long-term Study to Evaluate Safety and Persistence of GF-CART01

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma (FL)Primary Mediastinal Large B-Cell Lymphoma+1 more
GenomeFrontier Therapeutics TW Co., Ltd. 18
Not applicableActive Not RecruitingNCT05150561
What this trial is testing

Muscle Dysfunction in Patients With Haematological Diseases

Who this might be right for
Hematologic DiseasesAcute Myeloid LeukemiaAcute Lymphoid Leukemia+2 more
Rigshospitalet, Denmark 216
Early research (Phase 1)Study completedNCT03885947
What this trial is testing

VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies

Who this might be right for
Hematological MalignancyAcute Leukemia in RemissionAcute Lymphoblastic Leukemia in Remission+3 more
Alla Keyzner 7
Testing effectiveness (Phase 2)Ended earlyNCT00963872
What this trial is testing

Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+1 more
Masonic Cancer Center, University of Minnesota 31
Very early researchUnknownNCT04191941
What this trial is testing

Treatment of Hematological Malignancy With Novel CAR-T Cells.

Who this might be right for
B-cell Non Hodgkin LymphomaB-cell Acute Lymphoblastic LeukemiaMultiple Myeloma
Timmune Biotech Inc. 9
Early research (Phase 1)Study completedNCT06082596
What this trial is testing

Study of BEBT-908 in Subjects With Advanced Hematological Tumors

Who this might be right for
Relapsed or Refractory Non-Hodgkin's LymphomaRelapsed or Refractory Multiple Myeloma
BeBetter Med Inc 32
Early research (Phase 1)Not Yet RecruitingNCT07809139
What this trial is testing

A Clinical Study to Evaluate CHT101 Injection in Subjects With Relapsed/Refractory T-Cell and B-Cell Hematologic Malignancies

Who this might be right for
Hematological Malignancies
Nanjing Miracle Biotechnology Co., Ltd. 30
Testing effectiveness (Phase 2)Ended earlyNCT01139164
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)

Who this might be right for
Hematological Malignancies
Medical University of South Carolina 78
Testing effectiveness (Phase 2)Looking for participantsNCT07043894
What this trial is testing

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

Who this might be right for
Solid TumorsHematological TumorChildren+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)Study completedNCT00233454
What this trial is testing

Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia

Who this might be right for
Systemic Mastocytosis, Aggressive (ASM)Leukemia, Mast CellHematological Non-mast Cell Lineage Disease (AHNMD)
Jason Robert Gotlib 26
Testing effectiveness (Phase 2)Study completedNCT01227356
What this trial is testing

A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia

Who this might be right for
Health Care QualityHealth Care Evaluation
Uppsala University 112
Testing effectiveness (Phase 2)Study completedNCT01379209
What this trial is testing

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

Who this might be right for
Graft Versus Host Disease
Regimmune Corporation 68
Next Page